Biopharmaceutical CMO Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Rising demand for biologics and complex therapies: The increasing prevalence of chronic diseases and the development of...

Biosimilars Market size was valued at USD 25.10 Billion in 2022 and is expected to reach USD 91.81 Billion By 2030 and grow at a CAGR of 17.6% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Significant cost savings: Biosimilars, highly similar versions of existing biologic drugs, offer substantial cost...

The global insulin pump market size is estimated to reach USD 9.66 billion by 2030, registering to grow at a CAGR of 8.42% from 2025 to 2030 according to a new report by Grand View Research, Inc. The key factors driving the growth of the market are the technological advancements and the adoption of pumps over traditional methods. These pumps are very convenient for people who...

Foot Orthotic Insoles Market size was valued at USD 3.42 Billion in 2022 and is expected to reach USD 5.87 Billion By 2030 and grow at a CAGR of 7% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Increasing awareness of foot health: Growing knowledge about the benefits of proper foot support, from pain relief to...

Hepatitis B Vaccine Market size was valued at USD 7.9 billion in 2022 and is estimated to reach at USD 11.32 billion in 2030 and grow at a compound annual growth rate approx. CAGR of 4.6% predicted for the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Renewed global commitment to hepatitis B elimination: World Health Organization...

The Insulin Pump Market was valued at USD 4.40 Billion in 2022 and is expected to reach USD 14.82 Billion By 2030 and grow at a CAGR of 16.4% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Rising diabetes prevalence: The global burden of diabetes is steadily increasing, particularly type 1 diabetes, creating a...

The global insulin pump market size was valued at 1,700 million in 2023 and is poised to grow at a CAGR of 3.5% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study...